DD
67
4
OKE
74
-6
PVH
67
5
HOG
39
4
BWA
52
4
DTE
58
2
PG
60
4
PNC
67
3
LEN
61
8
STI
31
17
MSFT
53
3
FDX
46
3
ACN
50
-2
ADSK
68
-2
ILMN
46
4
PEP
50
2
UNH
63
4
FCX
61
3
PM
64
2
EA
59
-4
DD
67
4
OKE
74
-6
PVH
67
5
HOG
39
4
BWA
52
4
DTE
58
2
PG
60
4
PNC
67
3
LEN
61
8
STI
31
17
MSFT
53
3
FDX
46
3
ACN
50
-2
ADSK
68
-2
ILMN
46
4
PEP
50
2
UNH
63
4
FCX
61
3
PM
64
2
EA
59
-4
Financhill
Back

Cartesian Therapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
34

RNAC
Cartesian Therapeutics

Last Price:
18.29
Seasonality Move:
13.13%
Sell
20

NBY
NovaBay Pharmaceuticals

Last Price:
0.60
Seasonality Move:
1.46%
Sell
34
Cartesian Therapeutics (RNAC) is a Sell

Is Cartesian Therapeutics a Buy, Sell or Hold?

  • The current Cartesian Therapeutics [RNAC] share price is $17.91. The Score for RNAC is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • RNAC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
20
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.62. The Score for NBY is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

RNAC Stock Price Chart

What is Cartesian Therapeutics's stock price today?

  • The Cartesian Therapeutics share price today is $17.91
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RNAC is experiencing selling pressure, which indicates risk of future bearish movement.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.62
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing slight selling pressure.

RNAC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.68 Sell
Relative Strength Index (14 RSI): 45.67 Sell
Chaikin Money Flow: -71548 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.61 - 21.41) Sell
Bollinger Bands (100): (14.35 - 20.33) Buy

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.01 Buy
Relative Strength Index (14 RSI): 41.04 Sell
Chaikin Money Flow: -92985 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.61 - 0.75) Sell
Bollinger Bands (100): (0.27 - 1.39) Sell

RNAC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.6 Buy
20-day SMA: 18.93 Sell
50-day SMA: 19.41 Sell
200-day SMA: 19.97 Sell
8-day EMA: 17.91 Buy
20-day EMA: 18.67 Sell
50-day EMA: 18.89 Sell
200-day EMA: 20.92 Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.7 Sell
20-day SMA: 0.71 Sell
50-day SMA: 0.67 Sell
200-day SMA: 2.31 Sell
8-day EMA: 0.69 Sell
20-day EMA: 0.69 Sell
50-day EMA: 0.73 Sell
200-day EMA: 5.52 Sell

Cartesian Therapeutics Earnings Growth & RNAC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.90 per share, and an increase next year of $1.70 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.

Cartesian Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):